This move is archived. Current quotes and coverage live on the stock page.
Follow MBX
Microbix Biosystems Inc. is facing a notable decline in its stock price, raising concerns among investors.
Microbix Biosystems Inc. (MBX.TO) is experiencing a downturn, with its stock sliding by 3.23% in today’s trading session. This decline comes despite the company’s recent announcements about revenue growth and upcoming financial results, leaving investors questioning the sustainability of its performance.
Investor takeaway: Investors should be cautious as Microbix's recent performance may reflect underlying challenges despite promising revenue figures.
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$39.72M
52W high
$0.33
52W low
$0.21
1W change
+0.00%
Beta
0.54
Analyst Price Targets
Based on analyst covering MBX · as of Sep 17, 2026
Wall Street analysts forecast MBX stock price to rise 37.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+37.9% Upside
Current Price
C$0.29
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
42.8%
Annualized
90-Day Vol
47.0%
Annualized
Trend (90d)
-28.0%
Annualized drift
90d Mean
C$0.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.28 | C$0.24 – C$0.33 |
| 60 trading days | C$0.27 | C$0.22 – C$0.33 |
| 90 trading days | C$0.26 | C$0.20 – C$0.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Microbix's stock down 3.23% today
The market cap stands at approximately CA$42.6 million, reflecting concerns over profitability and investor confidence.
Bull case
Microbix reported a 13% increase in Q1 revenues, showing potential for growth if the company can effectively manage its operational losses.
Bear case
The current decline in stock price highlights investor skepticism, especially given the company’s negative profit margin and lack of dividends.
Recent Performance Overview
Microbix Biosystems Inc. saw its stock price decrease by 3.23% today, closing at CA$0.30. This decline is concerning, especially as the company recently reported a 13% revenue increase for Q1 2026, which has not translated into a positive market reaction.
Market Sentiment and Future Outlook
The current market sentiment appears cautious, with investors reacting negatively to the company’s ongoing operational losses, reflected in its profit margin of -38.62%. As Microbix prepares to release its Q2 fiscal results, the focus will be on whether it can turn around its financial performance and regain investor confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
